Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Gunawardene P, et al
Other Options May Be Better Suited For Patients Who: Specifically require FDA-approved finished products: Patients who need or prefer brand-name GLP-1 medications with full FDA approval status should clarify this directly with the evaluating clinician during intake, as the platform's primary offerings are compounded formulations
A., Thaalibi, H
Common causes include water retention (especially after dose increases or during hormonal fluctuations), muscle gain offsetting fat loss (particularly in people who are exercising consistently), metabolic adaptation, and changes in dietary habits that may have gradually increased caloric intake
clinicaltrials.gov/study/NCT03574 3
The company plans to sell a generic version of Novo Nordisk's diabetes drug, liraglutide